Literature DB >> 21876778

Coronary spasm-related acute myocardial infarction in a patient with essential thrombocythemia.

Chi-Wen Cheng1, Ming-Jui Hung.   

Abstract

We report a case of essential thrombocythemia (ET) in a 30-year-old female who exhibited inferior wall ST-elevation acute myocardial infarction (AMI) without significant obstructive coronary artery disease. Right coronary vasospasm was observed after intra-coronary methylergonovine administration and she received verapamil 120 mg/dthereafter and hydroxyurea 1500 mg/d for thrombocythemia. After discontinuation of the hydroxyurea for 9 mo based on the impression of coronary spasm-related instead of coronary thrombosis-related AMI, her platelet count rose but no chest pain was observed. It is suggested that coronary spasm potentially plays a role in patients with ET, AMI and no significant coronary artery stenosis.

Entities:  

Keywords:  Acute myocardial infarction; Coronary spasm; Essential thrombocythemia

Year:  2011        PMID: 21876778      PMCID: PMC3163243          DOI: 10.4330/wjc.v3.i8.278

Source DB:  PubMed          Journal:  World J Cardiol


  10 in total

1.  Essential thrombocythemia and recurrent myocardial infarction.

Authors:  H Kaya; M Gündogdu; S B Tekin; E Akarsu; E Bozkurt
Journal:  Clin Lab Haematol       Date:  2000-06

2.  Thrombocythemia and coronary artery disease.

Authors:  M G Scheffer; J J Michiels; M L Simoons; J R Roelandt
Journal:  Am Heart J       Date:  1991-08       Impact factor: 4.749

3.  Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia.

Authors:  Chor-Sang Chim; Yok-Lam Kwong; Albert Kwok-Wei Lie; Siu-Kwan Ma; Chi-Chung Chan; Lap-Gate Wong; Bonnie Chi San Kho; Harold-Kwok Lee; Joycelyn Pui-Yin Sim; Cheuk-Hung Chan; Joyce Chee-Wun Chan; Yiu-Ming Yeung; Martin Law; Raymond Liang
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

4.  Essential thrombocythaemia and recurrent myocardial infarction.

Authors:  P Douste-Blazy; M J Taudou; M Delay; J Pris; P Sie; L Ribaut; F Galinier; P Bernadet
Journal:  Lancet       Date:  1984-10-27       Impact factor: 79.321

5.  Thrombocytosis and fatal coronary heart disease.

Authors:  J E Saffitz; E R Phillips; P N Temesy-Armos; W C Roberts
Journal:  Am J Cardiol       Date:  1983-09-01       Impact factor: 2.778

6.  Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the Japanese Elderly Leukemia and Lymphoma Study Group.

Authors:  Kazuo Dan; Takashi Yamada; Yukihiko Kimura; Noriko Usui; Shinichirou Okamoto; Takashi Sugihara; Kazue Takai; Michihiko Masuda; Mayumi Mori
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 7.  Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia.

Authors:  M A Elliott; A Tefferi
Journal:  Br J Haematol       Date:  2005-02       Impact factor: 6.998

8.  Primary thrombocythemia and myocardial infarction in a 26-year-old woman with normal coronary arteriogram.

Authors:  N Okayasu; M Murata; A Ueda; K M Su; T Sada; T Ito; Y Hasegawa; S Matsumoto; Y Ito
Journal:  Jpn Heart J       Date:  1981-05

9.  Coronary vasospasm, multiple coronary thrombosis, unstable angina and essential thrombocytosis.

Authors:  K K Koh; S K Cho; S S Kim; B H Oh; Y W Lee
Journal:  Int J Cardiol       Date:  1993-09       Impact factor: 4.164

10.  Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors.

Authors:  Alexandra P Wolanskyj; Susan M Schwager; Rebecca F McClure; Dirk R Larson; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2006-02       Impact factor: 7.616

  10 in total
  3 in total

1.  What is the meaning of P2Y12 reaction units in patients with essential thrombocythemia?

Authors:  Shinya Goto; Shinichi Goto
Journal:  J Cardiol Cases       Date:  2015-09-11

2.  Peripartum myocardial infarction associated with coronary spasm and acquired protein S deficiency: A case report.

Authors:  Yoshiaki Oshima; Kazumasa Yamasaki; Akihiro Otsuki; Masato Nakasone; Ryo Endo; Naoki Moriyama; Seiji Sakamoto; Yukari Minami; Yoshimi Inagaki
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

3.  Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera.

Authors:  Éva Pósfai; Imelda Marton; Zita Borbényi; Attila Nemes
Journal:  Anatol J Cardiol       Date:  2016-02-04       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.